Sign inSubscribe
Headlines

BF Biosciences enters contract manufacturing deal with Lucky Core Industries

Agreement covers production of Esopase IV 40 mg and Etipro IV 40 mg

By News Desk

BF Biosciences Limited (BFBL), a subsidiary of Ferozsons Laboratories Limited, has signed a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI). 

The agreement involves the production of two pharmaceutical products: Esopase IV 40 mg and Etipro IV 40 mg.

This development was communicated by Ferozsons Laboratories in accordance with Section 96 of the Securities Act, 2015, and Clause 5.6.1(a) of PSX Regulations. 

The company requested that the relevant information be disseminated to the TREC Holders of the Pakistan Stock Exchange. 

Previous article
India’s economy to remain strong despite subdued global growth: World Bank 
Next article
Pakistan’s exports surge by 16% in August, hitting $2.74 billion
News Desk
News Desk

RELATED ARTICLES

Must Read

Headlines

Amin Khan Lodhi appointed SBP deputy governor for five years

Lodhi currently heads SBP’s monetary policy and research group, with over 20 years’ experience in monetary management, exchange rate policy, and economic research

Pakistan, China firms form joint consortium to develop regional logistics hub

PM orders international forensic audit of PRAL system after discovery of 2018-19 sales tax fraud

NFC awards

Govt to convene long-delayed NFC meeting on Nov 18 to revive revenue-sharing talks

Profit by Pakistan Today
Publishing Editor: Babar Nizami -- Editor Multimedia: Umar Aziz Khan -- Senior Editor: Abdullah Niazi -- Editorial Consultant: Ahtasam Ahmad -- Business Reporters: Taimoor Hassan | Shahab Omer l Zain Naeem | Shahnawaz Ali | Ghulam Abbass | Ahmad Ahmadani | Aziz Buneri -- Sub-Editor: Saddam Hussain -- Video Producer: Talha Farooqi -- Director Marketing : Mudassir Alam | Regional Heads of Marketing: Agha Anwer (Khi) | Kamal Rizvi (Lhe) | Malik Israr (Isb ) -- Manager Subscriptions: Irfan Farooq -- Pakistan’s #1 business magazine - your go-to source for business, economic and financial news.
Contact us: [email protected]
Copyright © 2025. Pakistan Today. All Rights Reserved.